Journal List > J Korean Ophthalmol Soc > v.50(1) > 1008504

Kyung, Hyun, and Man: Clinical Results of Phacoemulsification in Eyes With Acute Angle-Closure Glaucoma in the Aspect of Complications

Abstract

Purpose

To evaluate the intraoperative and postoperative complications and outcomes of phacoemulsification of cataract in eyes with prior iriodotomy for acute angle closure glaucoma.

Methods

This retrospective case-control study included 30 eyes which underwent phacoemulsification. All 30 eyes had prior acute angle closure treated by laser iridotomy (ACG group). A second group that had phacoemusification for cataract only served as control (Control group).

Results

The ACG group showed significantly shallow anterior chamber (1.56±0.18 mm) and short axial length (22.32±0.60 mm). At 2 months after surgery, visual acuity was improved in both groups and IOP was significantly decreased in the ACG group. Posterior synechiae, small pupil and zonulysis were more commonly found in the ACG group than the control group. Intraoperative iris trauma and postoperative persistent mydriasis were also more common in the ACG group.

Conclusions

During cataract surgery in eyes with prior iriodotomy for acute angle closure glaucoma, there are many preoperative risk factors such as shallow anterior chamber, zonulysis, and small pupil. These increase the risk of posterior capsule rupture and bullous keratopathy. To reduce the complications and improve the visual acuity, a careful preoperative examination and proper intra- and post-operative management by skillful surgeons are needed.

References

1. Imaizumi M, Takaki Y, Yamashita H. Phacoemulsification and intraocular lens implantation for acute angle closure not treated or previously treated by laser iridotomy. J Cataract Refract Surg. 2006; 32:85–90.
crossref
2. Choong YF, Irfan S, Menage MJ. Acute angle closure glaucoma: an evaluation of a protocol for acute treatment. Eye. 1999; 13:613–6.
crossref
3. Tello C, Tran HV, Liebmann J, Ritch R. Angle closure: classification, concepts, and the role of ultrasound bio-microscopy in diagnosis and treatment. Semin Ophthalmol. 2002; 17:69–78.
crossref
4. Quigley HA. Long-term follow-up of laser iridotomy. Ophthalmology. 1981; 88:218–24.
crossref
5. Wilensky JT, Kaufman PL, Frohlichstein D. . Follow-up of angle-closure glaucoma suspects. Am J Ophthalmol. 1993; 115:338–46.
crossref
6. McMahan LB, Monica ML, Zimmerman TJ. Posterior chamber pseudophakes in glaucoma patients. Ophthalmic Surg. 1986; 17:146–50.
crossref
7. Tong JT, Miller KM. Intraocular pressure change after sutureless phacoemulsification and foldable posterior chamber lens implantation. J Cataract Refract Surg. 1998; 24:256–62.
crossref
8. Byun SW, Park CK, Hahn TW, Kim MS. Results of combined procedures versus two-stage operation using small incision in patients with cataract and glaucoma. J Korean Ophthalmol Soc. 1999; 40:2561–6.
9. Lai JS, Tham CC, Chan JC. The clinical outcomes of cataract extraction by phacoemulsification in eyes with primary angle-closure glaucoma (PACG) and co-existing cataract: a prospective case series. J Glaucoma. 2006; 15:47–52.
crossref
10. Jacobi PC, Dietlein TS, Lüke C. . Primary phacoe-mulsification and intraocular lens implantation for acute angle-closure glaucoma. Ophthalmology. 2002; 109:1597–603.
11. Khokhar S, Sindhu N, Pangtey MS. Phacoemulsification in filtered chronic angle closure glaucoma eyes. Clin Experiment Ophthalmol. 2002; 30:256–60.
crossref
12. Kim YH, Hyung S. Effect of cataract extraction in chronic angle-closure glaucoma patients. J Korean Ophthalmol Soc. 2007; 48:521–6.
13. Yun YM, Yim JH, Kim CS. Clinical factors that influence intraocular pressure change after cataract surgery in primary open-angle glaucoma and angle-closure glaucoma. J Korean Ophthalmol Soc. 2006; 47:85–96.
14. Erie JC, Hodge DO, Gray DT. The incidence of primary angle-closure glaucoma in Olmsted County, Minnesota. Arch Ophthalmol. 1997; 115:177–81.
crossref
15. Ritch R, Lowe RF. Angle-closure glaucoma: therapeutic overview. The Glaucomas. 2nd. St Louis: Mosby;1996. p. 1521.
16. Ritch R, Solomon LD. Argon Laser Peripheral Iridoplasty for Angle-Closure Glaucoma in Sibilings with Weill-Marchesani Syndrome. J Glaucoma. 1992; 1:243–7.
crossref
17. Lim KJ, Hyung SM, Youn DH. Ocular dimensions with aging in normal eyes. Korean J Ophthalmol. 1992; 6:19–31.
crossref
18. An JW, On KK, Kim JD. Biometric measurements in acute angle closure glaucoma. J Korean Ophthalmol Soc. 1993; 34:648–53.
19. Kim YW, Kim SD, Kim JD. Influence of lens factor and effect of selected cataract extraction on acute angle-closure glaucoma. J Korean Ophthalmol Soc. 2005; 46:1144–50.
20. Kubota T, Toguri I, Onizuka N, Matsuura T. Phacoe-mulsification and intraocular lens implantation for angle closure glaucoma after the relief of pupillary block. Ophthal-mologica. 2003; 217:325–8.
crossref
21. Markowitz SN, Morin JD. The endothelium in primary angle-closure glaucoma. Am J Ophthalmol. 1984; 98:103–4.
crossref
22. Bigar F, Witmer R. Corneal endothelial changes in primary acute angle-closure glaucoma. Ophthalmology. 1982; 89:596–9.
crossref

Figure 1.
Types of cataract in study and control patients. NS=nuclear sclerosis; C=cortical; PSC= posterior subcap sular; Mixed=NS/cortical; PSC/cortical or NS/PSC/Cortical. There are no statistical significant difference between the two groups (P>0.05 in all cases).
jkos-50-44f1.tif
Figure 2.
Graphs demonstrating the course of the intraocular pressure (IOP) before and after phacoemulsification. At 1 and 2 months after surgery, intraocular pressure was significantly lowered in the angle-closure group (p=0.018, p=0.011).
jkos-50-44f2.tif
Table 1.
Preoperative and postoperative characteristics
ACG Control p-value
Age (years) 69.07±8.95 (48 to 80) 68.67±8.42 (50 to 81) 0.859
Gender Male 6 9
Female 24 21
IOP (mmHg) 16.53±2.97 (12 to21) 15.53±2.52 (9 to 20) 0.296
UCVA (logMAR) 0.80±0.11 (0.39 to 2.00) 0.74±0.42 (0.30 to 1.4 40)0.586
BCVA (logMAR) 0.63±0.42 (0.09 to 2.00) 0.60±0.40 (0.49 to 1.4 40)0.763
Medications (number) 1.33±1.09 (0 to 3) 0 0.000
Nucleus opacity score (§ LOCS III) 3.27±0.98 (2 to 6) 3.27±0.98 (2 to 6) 1.000

ACG=angle closure glaucoma;

UCVA=uncorrected visual acuity;

BCVA=best corrected visual acuity;

§ LOCS III=Lens Opacities Classification System III. Independent sample t-test.

Table 2.
Preoperative biometric characteristics
ACG Control P-value
Spherical equivalent (D) -2.09±2.96 (-4.25 to +3.75) -1.46±3.35 (-4.50 to +3.00) 0.564
Cylindrical refraction (D)1.24±1.28 (plano to 4.25) 1.46±1.46 (plano to 3.25) 0.613
A-scan biomicroscopy
ACD (mm)1.56±0.18 (1.17 to 1.85) 2.56±0.35 (1.89 to 3.32) 0.002
Lens thickness (mm)5.72±0.29 (5.32 to 6.27) 5.26±0.99 (3.52 to 6.26) 0.022
Axial length (mm) 22.32±0.60 (20.9 to 23.9) 23.48±1.03 (21.86 to 25.49) 0.054
LT to AL ratio factor 0.26±0.01 (0.24 to 0.27) 0.23±0.04 (0.15 to 0.26) 0.001
§ IOL power (D) 22.90±1.53 (20.5 to 26) 20.39±2.25 (16 to 23.5) 0.248
Endothelial cell count (mm2)2268.87±531.39 (1256 to 2932) 2592.40±372.69 (1814 to 3267) 0.004

ACG=angle closure glaucoma;

LT=lens thickness;

AL=axial length and

§ IOL=intraocular lens. Independent sample t-test.

Table 3.
Preoperative ocular characteristics
* ACG Control P-value
Posterior synechia 9 (30.0%) 0 (0%) 0.001
Persistent mydriasis 3 (10.0%) 0 (0%) 0.076
Small pupil requiring stretching or iris retractor (<5.0 mm) 11 (36.7%) 0 (0%) 0.001
Zonulysis 4 (13.3%) 0 (0%) 0.038
Lens subluxation 2 (6.7%) 0 (0%) 0.150

ACG=angle closure glaucoma. Pearson’s chi-square test.

Table 4.
Intraoperative observation and complications
Complications ACG Control P-value
Iris trauma 7 (23.3%) 1 (3.3%) 0.023
Hyphema 4 (13.3%) 0 (0%) 0.038
Unsuccessful CCC 2 (6.7%) 1 (3.3%) 0.554
Posterior capsule rupture 3 (10.0%) 1 (3.3%) 0.301
Without anterior vitrectomy 1 (3.3%) 1 (3.3%)
With anterior vitrectomy 2 (6.7%) 0 (0%)
Radial tear during capsulorhexis or phacoemulsification 3 (10.0%) 0 (0%) 0.076
Dropped nuclear fragment 1 (3.3%) 0 (0%) 0.313

ACG=angle closure glaucoma;

CCC=continuous curvilinear capsulorhexis. Pearson’s chi-square test.

Table 5.
Intraoperative additional procedures
Additional procedures ACG Control P-value
Synechiolysis 9 (30.0%) 0 (0%) 0.001
Tension ring implantation 2 (6.7%) 0 (0%) 0.150
IOL implantation into the sulcus 3 (10.0%) 1 (3.3%) 0.301
IOL scleral fixation 2 (6.7%) 0 (0%) 0.150

ACG=angle closure glaucoma;

IOL=intraocular lens. Pearson’s chi-square test.

Table 6.
Postoperative complications.
Complications ACG Control P-value
Persistent mydriasis 7 (23.3%) 0 (0%) 0.005
Corneal edema 8 (26.7%) 3 (10.0%) 0.095
Hyphema 4 (13.3%) 0 (0%) 0.038
Vitreous tractional membrane requiring Nd:YAG 2 (6.7%) 0 (0%) 0.150
Increased in intraocular pressure (≥25 mmHg) 2 (6.7%) 0 (0%) 0.150
Bullous keratopathy 1 (3.3%) 0 (0%) 0.313

ACG=angle closure glaucoma. Pearson’s chi-square test.

TOOLS
Similar articles